AEON Biopharma is a biopharmaceutical company focused on the development of ABP-450, a proprietary 900 kDabotulinum toxin complex, for debilitating medical conditions. The company is headquartered in Newport Beach, California and currently employs 6 full-time employees. The company went IPO on 2021-10-08. The firm is focused on developing botulinum toxin complex, ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions. The biologic ingredient in ABP-450 is Clostridium botulinum toxin, type A with a molecular weight of 900 kDa. Its initial development programs for ABP-450 are focused on migraine, cervical dystonia and gastroparesis. Migraine is a neurological condition characterized by recurrent episodes of headaches. The firm is developing ABP-450 for the preventative treatment of migraine, which is inclusive of both chronic migraine and episodic migraine. Cervical dystonia is a neurological condition characterized by involuntary muscle contractions of the neck which may present as spasms, contractions or abnormal posture. Gastroparesis is a gastrointestinal disorder characterized by the slowing or stoppage of movement of food and liquid from the stomach to the small intestine.
AEON stock price ended at $0 on Friday, after dropping NaN%
On the latest trading day May 01, 2026, the stock price of AEON fell by NaN%, dropping from $NaN to $NaN. During the session, the stock saw a volatility of NaN%, with prices oscillating between a daily low of $NaN and a high of $NaN. On the latest trading day, the trading volume for AEON decreased by -- shares, aligning with the declining prices, which may indicate weakening market confidence in the near term. In total, -- shares were traded, with a market value of approximately --.
AEON Technical Signals
Technical Signals Summary
Buy Signals 0
Neutral Signals 7
Sell Signals 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
AEON currently exhibits 0 buy signals and 0 sell signals. The stock has been in an downtrend since --, with a total price change of -- during this period. Overall, the technical indicators point to a Neutral outlook for the mid-term.
Bullish/Bearish Signals for AEON
Our algorithms analyze key indicators like moving averages, RSI, MACD, and trading volume to generate bullish and bearish signals for AEON. These insights help you make informed investment decisions.
Follow-Up Questions
How do technical analysis indicators apply to AEON?
According to technical analysis, AEON Biopharma Inc has an aggregate signal of Neutral. AEON Biopharma Inc has 0 Buy signals, 7 Neutral Signals and 0 sell signals.
What is the RSI for AEON Biopharma Inc?
The RSI for AEON Biopharma Inc is currently 0, indicating a neutral condition
What is AEON Biopharma Inc price for the next 12 months?
AEON Biopharma Inc AEON price for the next 12 months is estimated at $0.
How high is AEON Biopharma Inc expected to go?
According to wall street analysts, AEON Biopharma Inc is expected to reach a high forecast of $0.